Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient and Visitor Info
  • Physicians
  • Services
  • Clinical Trials
  • Event Calendar
  • Locations
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Clinical Trials > Vitamin D Add-On Therapy Enhances Corticosteriod Responsiveness in Asthma (VIDA)
Jumbo Large Regular Text:
Print
Clinical Trials

Vitamin D Add-On Therapy Enhances Corticosteriod Responsiveness in Asthma (VIDA)

Related Content

Health Articles

  • Understanding Clinical Trials: A participants' guide

In This Section

Related Clinical Trials

  • Asthma and Allergies
  • Pulmonology and Respiratory Medicine

Share

VIDA is a study aimed at improving the health of people with asthma who still have asthma symptoms despite using low-dose inhaled asthma medications (inhaled corticosteroids) and who are deficient in vitamin D.

Eligibility Requirements

To qualify, participants must:

  • Be age 18 or older
  • Have persistent asthma symptoms 
  • Use low-dose inhaled corticosteroid
  • Have low vitamin D levels (< 30 ng/ml)
  • Use vitamin D supplements < 1000 IU/day

Study Requirements

Participants must:

  • Undergo a screening visit
  • Take study medications that are provided at no cost to you 
  • Participate in a total of 11 visits over 35 weeks

Compensation

Financial compensation will be provided for qualified participants.

For more information, contact Rhonda Webb at 919-479-0743 or rhonda.webb@duke.edu.


(REF# 27628)
Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En Español | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: Oct. 4, 2011
Published: Oct. 4, 2011
URL: http://www.dukehealth.org/clinicaltrials/vitamin-d-add-on-therapy-enhances-corticosteroid-responsiveness-in-asthma